Related Experiment Video

Updated: Jul 19, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST

Mikhail V Semenov1, Xi He

  • 1Neurobiology Program, Children's Hospital Boston, 61 Binmney Street, Boston, MA 02115, USA. mikhail.semenov@childrens.harvard.edu

The Journal of Biological Chemistry
|October 21, 2006
PubMed

Insights

Mutations in low-density lipoprotein receptor-related protein 5 (LRP5) cause osteoporosis or high bone mass. We found high bone mass mutations reduce SOST binding, suggesting SOST-LRP5 interaction is key for bone mass regulation and therapeutic targeting.

Area of Science:

  • Biochemistry
  • Genetics
  • Bone Biology

Background:

  • Low-density lipoprotein receptor-related protein 5 (LRP5) is crucial for bone homeostasis, acting as a Wnt co-receptor.
  • Genetic variations in LRP5 are linked to osteoporosis (loss-of-function) and high bone mass (HBM) diseases (dominant mutations).
  • HBM-associated LRP5 mutations cluster in the extracellular domain, potentially increasing Wnt signaling in bone cells.

Purpose of the Study:

  • To investigate the mechanism by which dominant LRP5 mutations lead to high bone mass.
  • To determine the impact of LRP5 HBM mutations on the interaction with the bone-specific antagonist, SOST.
  • To explore the therapeutic potential of targeting the SOST-LRP5 interaction for bone diseases.

Main Methods:

  • Analysis of LRP5 HBM mutant proteins.
  • Assessment of SOST binding affinity to wild-type and mutant LRP5.
  • Evaluation of SOST's inhibitory effect on LRP5 activity in the presence of HBM mutations.

Main Results:

  • LRP5 HBM mutant proteins demonstrate significantly reduced binding to SOST.
  • Mutant LRP5 proteins are less sensitive to inhibition by SOST compared to wild-type LRP5.
  • This impaired interaction suggests a mechanism for elevated Wnt signaling in HBM.

Conclusions:

  • The SOST-LRP5 antagonistic interaction is a critical regulator of bone mass.
  • Reduced SOST binding to LRP5 is associated with high bone mass phenotypes.
  • Targeting the SOST-LRP5 pathway offers a potential therapeutic strategy for osteoporosis and other bone disorders.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...